Elizabeth Arden, Inc.
Elizabeth Arden, Inc. Fundamental Analysis
Elizabeth Arden, Inc. (RDEN) shows weak financial fundamentals with a PE ratio of -5.68, profit margin of -7.60%, and ROE of -76.58%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -95.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze RDEN's fundamental strength across five key dimensions:
Efficiency Score
WeakRDEN struggles to generate sufficient returns from assets.
Valuation Score
ExcellentRDEN trades at attractive valuation levels.
Growth Score
WeakRDEN faces weak or negative growth trends.
Financial Health Score
ModerateRDEN shows balanced financial health with some risks.
Profitability Score
WeakRDEN struggles to sustain strong margins.
Key Financial Metrics
Is RDEN Expensive or Cheap?
P/E Ratio
RDEN trades at -5.68 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, RDEN's PEG of -0.06 indicates potential undervaluation.
Price to Book
The market values Elizabeth Arden, Inc. at 7.01 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 14.74 times EBITDA. This signals the market has high growth expectations.
How Well Does RDEN Make Money?
Net Profit Margin
For every $100 in sales, Elizabeth Arden, Inc. keeps $-7.60 as profit after all expenses.
Operating Margin
Core operations generate -7.15 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-76.58 in profit for every $100 of shareholder equity.
ROA
Elizabeth Arden, Inc. generates $-9.19 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-1.53 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-5.68
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.06
vs 25 benchmark
P/B Ratio
Price to book value ratio
7.01
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
7.08
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.59
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.77
vs 25 benchmark
ROA
Return on assets percentage
-0.09
vs 25 benchmark
ROCE
Return on capital employed
-0.13
vs 25 benchmark
How RDEN Stacks Against Its Sector Peers
| Metric | RDEN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -5.68 | 22.44 | Better (Cheaper) |
| ROE | -76.58% | 1180.00% | Weak |
| Net Margin | -7.60% | -3990.00% (disorted) | Weak |
| Debt/Equity | 7.08 | 1.21 | Weak (High Leverage) |
| Current Ratio | 1.59 | 2.53 | Neutral |
| ROA | -9.19% | -192044.00% (disorted) | Weak |
RDEN outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Elizabeth Arden, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Dividend, Low Volatility
EPS CAGR
N/A
Industry Style: Defensive, Dividend, Low Volatility
FCF CAGR
N/A
Industry Style: Defensive, Dividend, Low Volatility